ALTEOGEN Inc. (KOSDAQ:196170)
South Korea · Delayed Price · Currency is KRW 550,000
-4,000 (-0.72%)
Nov 17, 2025, 1:50 PM KST
ALTEOGEN Market Cap
ALTEOGEN has a market cap or net worth of 29.63 trillion as of November 14, 2025. Its market cap has increased by 44.30% in one year.
Market Cap
29.63T
Enterprise Value
29.37T
Revenue
158.06B
Ranking
n/a
PE Ratio
314.24
Stock Price
550,000.00
Market Cap Chart
Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 29.63T, an increase of 24,600.02%. That is a compound annual growth rate of 65.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 29.63T | 79.63% |
| Dec 30, 2024 | 16.49T | 221.05% |
| Dec 28, 2023 | 5.14T | 160.78% |
| Dec 29, 2022 | 1.97T | -38.41% |
| Dec 30, 2021 | 3.20T | -36.62% |
| Dec 30, 2020 | 5.05T | 442.81% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 43.20T |
| SK Biopharmaceuticals | 10.05T |
| ABL Bio | 9.60T |
| Yuhan | 9.35T |
| Peptron | 7.22T |
| HLB Co., Ltd. | 6.50T |
| LigaChem Biosciences | 6.39T |